Ciliary Madarosis Secondary to Intra-Arterial Chemotherapy for Retinoblastoma Treatment

In the study titled "Ciliary Madarosis Secondary to Intra-Arterial Chemotherapy for Retinoblastoma Treatment," it is noted that ciliary madarosis, or eyelash loss, can occur as a temporary side effect of intra-arterial chemotherapy (IAC) used in treating retinoblastoma. This condition, while not permanent, may cause discomfort for both patients and their families. A thorough physical examination and trichoscopic evaluation of the affected area are essential for quickly diagnosing and determining the prognosis of this specific type of alopecia.